Methoxetamine
Methoxetamine (MXE, 3-MeO-2'-Oxo-PCE) is a dissociative anesthetic that has been sold as a designer drug. It is a derivative of ketamine that also contains structural features of eticyclidine and 3-MeO-PCP. Methoxetamine is thought to behave as a NMDA receptor antagonist and dopamine reuptake inhibitor, but it has not been formally studied in animals and it lacks a MEDLINE indexed name.
History[edit]
Methoxetamine was first synthesized in 2010 by a chemist who was trying to recreate the effects of ketamine for less cost. It was first sold commercially in 2010.
Pharmacology[edit]
Methoxetamine is thought to behave as a NMDA receptor antagonist and dopamine reuptake inhibitor, but it has not been formally studied in animals and it lacks a MEDLINE indexed name. It is a derivative of ketamine that also contains structural features of eticyclidine and 3-MeO-PCP.
Effects[edit]
The effects of methoxetamine are similar to those of ketamine but typically longer lasting. The drug produces a feeling of detachment from one's physical body and the external world, known as dissociation. Other effects include hallucinations, euphoria, and memory loss.
Legal status[edit]
Methoxetamine is a controlled substance in many countries, including the United States, the United Kingdom, and Australia.
See also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Methoxetamine[edit]
-
Methoxetamine 2D Structure
-
MXE
-
Methoxetamine
-
Arylcyclohexylamines
-
Methoxetamine
